Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The Time Between Chemoradiation and Surgery for Rectal Carcinoma Negatively Influences Mesorectal Excision Quality

I. Sirák, D. Pohanková, A. Ferko, E. Hovorková, T. Rozkoš, M. Vošmik, M. Hodek, P. Paluska, D. Buka, J. Grepl, J. Petera

. 2020 ; 26 (3) : 1565-1572. [pub] 20190903

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21020414

Total mesorectal excision quality (TMEq) is a prognostic factor associated with local recurrence in rectal adenocarcinoma. Neoadjuvant chemoradiotherapy (NCRT) reduces the risk of tumor recurrence, but may compromise TMEq. The time between NCRT and surgery (TTS) and how it influences TMEq and tumor control were evaluated. In prospective registry, 236 patients after NCRT and TME were analyzed. NCRT involved radiotherapy with 45 Gy to the pelvis, plus tumor boost dose 5.4 Gy with concurrent 5-fluorouracil infusion. NCRT was followed by TME after 9 weeks on average (median 9.4 ± SD 2.5). TMEq was parametrically analyzed by standard three-grade system. With median follow-up of 47.5 months, 3-year overall survival (OS) was 83.8%, disease-free survival (DFS) was 77.7%, and 6.4% was the rate of local recurrence (LR). TTS was not associated with OS, DFS, or LR. TMEq was found to be associated with LR in univariate analysis, but not in multivariate, where pathological tumor stage and resection margins remained dominant predictors. TMEq was negatively influenced by inferior location of the tumor, longer TTS, higher tumor and nodal stage, presence of tumor perforation, perineural invasion, and close/positive resection margins. Nonetheless, TTS remained a strong predictor of TMEq in multivariate analyses. TTS was proven to be an independent predictor of TMEq. With longer TTS, fewer complete TME with intact mesorectal plane were observed. However, TTS was not associated with survival deterioration or tumor recurrence. These were negatively influenced by other factors interfering with TMEq, especially by pathological tumor stage and resection margins.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21020414
003      
CZ-PrNML
005      
20210830102118.0
007      
ta
008      
210728s2020 sz f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s12253-019-00742-w $2 doi
035    __
$a (PubMed)31482400
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Sirák, Igor $u Department of Oncology and Radiotherapy, University Hospital in Hradec Kralove, Sokolská 581, 500 05, Hradec Králové, Czech Republic
245    14
$a The Time Between Chemoradiation and Surgery for Rectal Carcinoma Negatively Influences Mesorectal Excision Quality / $c I. Sirák, D. Pohanková, A. Ferko, E. Hovorková, T. Rozkoš, M. Vošmik, M. Hodek, P. Paluska, D. Buka, J. Grepl, J. Petera
520    9_
$a Total mesorectal excision quality (TMEq) is a prognostic factor associated with local recurrence in rectal adenocarcinoma. Neoadjuvant chemoradiotherapy (NCRT) reduces the risk of tumor recurrence, but may compromise TMEq. The time between NCRT and surgery (TTS) and how it influences TMEq and tumor control were evaluated. In prospective registry, 236 patients after NCRT and TME were analyzed. NCRT involved radiotherapy with 45 Gy to the pelvis, plus tumor boost dose 5.4 Gy with concurrent 5-fluorouracil infusion. NCRT was followed by TME after 9 weeks on average (median 9.4 ± SD 2.5). TMEq was parametrically analyzed by standard three-grade system. With median follow-up of 47.5 months, 3-year overall survival (OS) was 83.8%, disease-free survival (DFS) was 77.7%, and 6.4% was the rate of local recurrence (LR). TTS was not associated with OS, DFS, or LR. TMEq was found to be associated with LR in univariate analysis, but not in multivariate, where pathological tumor stage and resection margins remained dominant predictors. TMEq was negatively influenced by inferior location of the tumor, longer TTS, higher tumor and nodal stage, presence of tumor perforation, perineural invasion, and close/positive resection margins. Nonetheless, TTS remained a strong predictor of TMEq in multivariate analyses. TTS was proven to be an independent predictor of TMEq. With longer TTS, fewer complete TME with intact mesorectal plane were observed. However, TTS was not associated with survival deterioration or tumor recurrence. These were negatively influenced by other factors interfering with TMEq, especially by pathological tumor stage and resection margins.
650    _2
$a adenokarcinom $x terapie $7 D000230
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a adjuvantní chemoradioterapie $x metody $7 D059186
650    _2
$a kombinovaná terapie $x metody $7 D003131
650    _2
$a chirurgie trávicího traktu $x metody $7 D013505
650    _2
$a přežití bez známek nemoci $7 D018572
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    12
$a resekční okraje $7 D000072662
650    _2
$a lidé středního věku $7 D008875
650    _2
$a neoadjuvantní terapie $x metody $7 D020360
650    _2
$a lokální recidiva nádoru $x epidemiologie $7 D009364
650    _2
$a nádory rekta $x terapie $7 D012004
650    _2
$a časové faktory $7 D013997
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
700    1_
$a Pohanková, Denisa $u Department of Oncology and Radiotherapy, University Hospital in Hradec Kralove, Sokolská 581, 500 05, Hradec Králové, Czech Republic
700    1_
$a Ferko, Alexander $u Department of Surgery and Transplant centre, Jessenius Faculty in Martin, University Hospital Martin, Comenius University Bratislava, Bratislava, Slovak Republic
700    1_
$a Hovorková, Eva $u Fingerland Department of Pathology, University Hospital in Hradec Králové, Hradec Králové, Czechia
700    1_
$a Rozkoš, Tomáš $u Fingerland Department of Pathology, University Hospital in Hradec Králové, Hradec Králové, Czechia
700    1_
$a Vošmik, Milan $u Department of Oncology and Radiotherapy, University Hospital in Hradec Kralove, Sokolská 581, 500 05, Hradec Králové, Czech Republic. milan.vosmik@fnhk.cz
700    1_
$a Hodek, Miroslav $u Department of Oncology and Radiotherapy, University Hospital in Hradec Kralove, Sokolská 581, 500 05, Hradec Králové, Czech Republic
700    1_
$a Paluska, Petr $u Department of Oncology and Radiotherapy, University Hospital in Hradec Kralove, Sokolská 581, 500 05, Hradec Králové, Czech Republic
700    1_
$a Buka, David $u Department of Oncology and Radiotherapy, University Hospital in Hradec Kralove, Sokolská 581, 500 05, Hradec Králové, Czech Republic
700    1_
$a Grepl, Jakub $u Department of Oncology and Radiotherapy, University Hospital in Hradec Kralove, Sokolská 581, 500 05, Hradec Králové, Czech Republic
700    1_
$a Petera, Jiří $u Department of Oncology and Radiotherapy, University Hospital in Hradec Kralove, Sokolská 581, 500 05, Hradec Králové, Czech Republic
773    0_
$w MED00180530 $t Pathology oncology research : POR $x 1532-2807 $g Roč. 26, č. 3 (2020), s. 1565-1572
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31482400 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830102118 $b ABA008
999    __
$a ok $b bmc $g 1691064 $s 1140860
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 26 $c 3 $d 1565-1572 $e 20190903 $i 1532-2807 $m Pathology oncology research $n Pathol Oncol Res $x MED00180530
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace